Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
10:18:57 08/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.115 USD | -0.48% |
|
+0.65% | +13.45% |
| 19/08 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -3.13x | 1.51x | 0.11x | 568.6x | -1.53x | -1.54x | -.--% | 36Cr | ||
| 32.76x | 4.38x | 1.23x | 5.88x | 17.63x | 24.66x | 0.99% | 4.84TCr | ||
| -21.5x | 22.2x | -0.33x | 245.64x | -23.19x | -21.81x | -.--% | 4.5TCr | ||
| 34.48x | 6.3x | -36.03x | 3.33x | 14.35x | 21.68x | -.--% | 4.41TCr | ||
| 46.93x | 7.94x | 0.23x | 5.43x | 29.72x | 34.2x | -.--% | 4.07TCr | ||
| 28.26x | 2.29x | 0.58x | 8.5x | 21.55x | 25.59x | 0.4% | 3.32TCr | ||
| 33.62x | 24.12x | 2.23x | 5.51x | 25.02x | 26.17x | -.--% | 1.65TCr | ||
| 23.87x | 2.67x | 0.69x | 2.08x | 9x | 13.93x | 1.13% | 1.45TCr | ||
| 77.18x | 4.57x | -0.34x | 4.06x | 15.75x | 19.35x | -.--% | 1.38TCr | ||
| 27.98x | 1.33x | 0.27x | 1.85x | 11.36x | 12.93x | -.--% | 1.27TCr | ||
| -46x | 23.7x | 123.08x | 7.63x | 186.93x | -2486.48x | -.--% | 1.17TCr | ||
| 52.42x | 4.57x | 2.74x | 8.7x | 24.69x | 29.45x | 0.44% | 1.14TCr | ||
| 38.03x | 4.37x | 2.45x | 4.49x | 19.22x | 30.89x | 0.59% | 1.04TCr | ||
| -25.33x | 8.75x | -8.29x | 10575.2x | -20.89x | -20.57x | -.--% | 982.25Cr | ||
| -27.62x | 8.13x | 1.04x | 99.23x | -28.25x | -49.15x | -.--% | 992.72Cr | ||
| -30.32x | 8.81x | -6.14x | 80.33x | -20.25x | -19.64x | -.--% | 976.11Cr | ||
| -15.96x | 672.49x | -0.3x | 10.46x | -16.79x | -16.19x | -.--% | 965.36Cr | ||
| 31.33x | - | -0.1x | 16.4x | 29.92x | 29.23x | -.--% | 942.93Cr | ||
| 22.57x | 2.4x | -32.17x | 4.51x | 12.06x | 15.41x | 0.31% | 898.96Cr | ||
| Average | 14.72x | 45.03x | 2.68x | 613.57x | 16.12x | -122.73x | 0.2% | 1.9TCr | |
| Weighted average by Cap. | 20.22x | 27.21x | -1.11x | 329.17x | 15.20x | -67.98x | 0.25% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















